BioLineRx Ltd.
BLRX
$3.39
$0.020.56%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.35M | 20.88M | 25.21M | 28.16M | 26.37M |
| Total Receivables | 1.89M | 456.00K | 699.00K | 281.00K | 1.92M |
| Inventory | 2.16M | 2.15M | 2.18M | 2.85M | 3.32M |
| Prepaid Expenses | 181.00K | 201.00K | 432.00K | 572.00K | 312.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 21.58M | 23.68M | 28.52M | 31.86M | 31.92M |
|
|
|||||
| Total Current Assets | 21.58M | 23.68M | 28.52M | 31.86M | 31.92M |
| Net Property, Plant & Equipment | 867.00K | 856.00K | 892.00K | 997.00K | 1.16M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.35M | 16.37M | 10.39M | 10.41M | 10.43M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 38.80M | 40.91M | 39.80M | 43.27M | 43.51M |
|
|
|||||
| Total Accounts Payable | 4.91M | 3.49M | 3.54M | 3.47M | 4.69M |
| Total Accrued Expenses | -- | 1.21M | 2.13M | 2.77M | 1.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.73M | 4.71M | 4.78M | 4.89M | 5.12M |
| Total Finance Division Other Current Liabilities | 3.99M | 2.71M | 3.23M | 4.36M | 2.46M |
| Total Other Current Liabilities | 3.99M | 2.71M | 3.23M | 4.36M | 2.46M |
| Total Current Liabilities | 13.62M | 12.12M | 13.67M | 15.48M | 14.03M |
|
|
|||||
| Total Current Liabilities | 13.62M | 12.12M | 13.67M | 15.48M | 14.03M |
| Long-Term Debt | 3.36M | 4.46M | 5.60M | 6.72M | 7.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 979.00K | 977.00K | 1.00M | 998.00K | 985.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.96M | 17.56M | 20.27M | 23.20M | 22.65M |
|
|
|||||
| Common Stock & APIC | 401.01M | 401.01M | 400.69M | 399.29M | 396.20M |
| Retained Earnings | -402.60M | -401.00M | -399.62M | -398.64M | -394.70M |
| Treasury Stock & Other | 18.26M | 18.19M | 18.47M | 19.42M | 19.37M |
| Total Common Equity | 16.67M | 18.20M | 19.53M | 20.07M | 20.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.67M | 18.20M | 19.53M | 20.07M | 20.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 4.16M | 5.15M | -- | -- | -- |
| Total Equity | 20.84M | 23.35M | 19.53M | 20.07M | 20.86M |
|
|
|||||